AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Endoscopic evaluation of the gastrotolerance of short-term antalgic treatment with low dose k-diclofenac: a comparison of ibuprofen and aspirin
Authors: Mahe, I Mouly, S Mahe, E Diemer, M Knellwolf, AL Simoneau, G Caulin, C Bergmann, JF
Citation: I. Mahe et al., Endoscopic evaluation of the gastrotolerance of short-term antalgic treatment with low dose k-diclofenac: a comparison of ibuprofen and aspirin, FUN CL PHAR, 15(1), 2001, pp. 61-63
Acute-onset rapidly fatal amebic dysentery in metropolitan France
Authors: Mahe, I Delahaye, V Caulin, C Bergmann, JF
Citation: I. Mahe et al., Acute-onset rapidly fatal amebic dysentery in metropolitan France, PRESSE MED, 30(26), 2001, pp. 1295-1297
The Transparency Commission: evaluation and reevaluation
Authors: Bergmann, JF
Citation: Jf. Bergmann, The Transparency Commission: evaluation and reevaluation, PRESSE MED, 30(19), 2001, pp. 941-946
Irritable bowel syndrome and quality of life
Authors: Chassany, O Bergmann, JF
Citation: O. Chassany et Jf. Bergmann, Irritable bowel syndrome and quality of life, GASTRO CL B, 25, 2001, pp. C54-C62
The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia.
Authors: Ducimetiere, P Signeyrole, D Giral, P Hoog-Labouret, N Amarenco, P Chanu, B Chauvenet, M Coletti, M Dallongeville, J Durlach, V Kawka, G Krempf, M Leroux, G Mlika-Cabanne, N Monnier, L Paillard, F Rostoker, G Sicard, D Verny, C Voiriot, P Acquart, B Alquier, G Ankri, J Badoc, G Basdevant, A Belmin, J Berthezene, F Beucler, I Blanc, F Broustet, JP Bruckert, E Brun, JM Castaigne, A Charpentier, JM Andre, MC Cogneau, J Demeaux, JL Denolle, T Desson, JF Drahi, E Drouin, P Dumel, F Emmerich, J Farnier, M Fontbonne, A Forette, B Gambert, P Gautier, JC Guillausseau, PJ Hommel, M Janowski, M Le Goaziou, MF Lievre, M Le Quere, M Leys, D Marechaud, R Mas, JL Menard, J Michel, JM Mounier-Vehier, F Mottier, D Passa, P Pinel, JF Puel, J Raccah, D Renou, P Ribier, A Schlienger, JL Thomas, D Vallee, JP Veyssier-Belot, C Bouvenot, G Abadie, E Alexandre, JM Belorgey-Bismut, C Bergmann, JF Camelli, B Caulin, C Costagliola, D Denis, C Dupuis, B Fleurette, F Guillevin, L Hoog-Labouret, N Paintaud, G Rauss, A Poynard, T Rostoker, G Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110
Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome - a population pharmacokinetic study
Authors: Mouly, S Aymard, G Tillement, JP Caulin, C Bergmann, JF Urien, S
Citation: S. Mouly et al., Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome - a population pharmacokinetic study, BR J CL PH, 51(6), 2001, pp. 557-565
Interaction between aspirin and ACE inhibitors in patients with heart failure
Authors: Mahe, I Meune, C Diemer, M Caulin, C Bergmann, JF
Citation: I. Mahe et al., Interaction between aspirin and ACE inhibitors in patients with heart failure, DRUG SAFETY, 24(3), 2001, pp. 167-182
Oral ganciclovir systemic exposure is enhanced in HIV-infected patients with diarrhea and weight loss
Authors: Mouly, S Aymard, G Diquet, B Caulin, C Bergmann, JF
Citation: S. Mouly et al., Oral ganciclovir systemic exposure is enhanced in HIV-infected patients with diarrhea and weight loss, J ACQ IMM D, 24(4), 2000, pp. 344-351
Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formulation versus regular formulation in healthy volunteers
Authors: Blondon, H Barbier, JP Mahe, I Deverly, A Kolsky, H Bergmann, JF
Citation: H. Blondon et al., Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formulation versus regular formulation in healthy volunteers, FUN CL PHAR, 14(2), 2000, pp. 155-157
Which aspirin dose after carotid endarteriectomy?
Authors: Bergmann, JF
Citation: Jf. Bergmann, Which aspirin dose after carotid endarteriectomy?, PRESSE MED, 29(18), 2000, pp. 1012-1012
The multifactorial cardiovascular risk
Authors: Mahe, I Bergmann, JF
Citation: I. Mahe et Jf. Bergmann, The multifactorial cardiovascular risk, PRESSE MED, 29(1), 2000, pp. 47-54
Pharmacokinetics of reboxetine in healthy, elderly volunteers
Authors: Bergmann, JF Laneury, JP Duchene, P Fleishaker, JC Houin, G Segrestaa, JM
Citation: Jf. Bergmann et al., Pharmacokinetics of reboxetine in healthy, elderly volunteers, EUR J DRUG, 25(3-4), 2000, pp. 195-198
PEP trial
Authors: Mahe, I Bergmann, JF Mahe, E Caulin, C
Citation: I. Mahe et al., PEP trial, LANCET, 356(9225), 2000, pp. 248-248
Drug-induced diarrhoea
Authors: Chassany, O Michaux, A Bergmann, JF
Citation: O. Chassany et al., Drug-induced diarrhoea, DRUG SAFETY, 22(1), 2000, pp. 53-72
Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review
Authors: Meune, C Mahe, I Mourad, JJ Simoneau, G Knellwolf, AL Bergmann, JF Caulin, C
Citation: C. Meune et al., Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review, EUR J CL PH, 56(9-10), 2000, pp. 609-620
Survey of the negativation of sputum samples in patients with active pulmonary tuberculosis: what is the optimum duration for the isolation?
Authors: Denis, V Salord, JM Raskine, L Sanson-Le Pors, MJ Diemer, M Caulin, C Bergmann, JF
Citation: V. Denis et al., Survey of the negativation of sputum samples in patients with active pulmonary tuberculosis: what is the optimum duration for the isolation?, ANN MED IN, 151(8), 2000, pp. 618-623
Prevention of venous thrombosis in medical patients.
Authors: Bergmann, JF Mahe, I
Citation: Jf. Bergmann et I. Mahe, Prevention of venous thrombosis in medical patients., ANN MED IN, 151(3), 2000, pp. 207-214
Authors are creating database of quality of life questionnaires
Authors: Chassany, O Bergmann, JF Caulin, C
Citation: O. Chassany et al., Authors are creating database of quality of life questionnaires, BR MED J, 318(7191), 1999, pp. 1142-1142
Treatment of gastro-oesophageal reflux disease in adults - Efficacy of surgery needs to be compared with that of proton pump inhibitors
Authors: Chassany, O Bergmann, JF Caulin, C
Citation: O. Chassany et al., Treatment of gastro-oesophageal reflux disease in adults - Efficacy of surgery needs to be compared with that of proton pump inhibitors, BR MED J, 318(7175), 1999, pp. 59-59
Bed rest for sciatica
Authors: Bergmann, JF
Citation: Jf. Bergmann, Bed rest for sciatica, PRESSE MED, 28(22), 1999, pp. 1169-1170
Opinion on interferon-ribavirin association for the first-intention treatment of chronic hepatitis C
Authors: Bergmann, JF
Citation: Jf. Bergmann, Opinion on interferon-ribavirin association for the first-intention treatment of chronic hepatitis C, PRESSE MED, 28(2), 1999, pp. 77-78
Eradication of Helicobacter pylori does not significantly improve dyspepsia - Comment
Authors: Bergmann, JF
Citation: Jf. Bergmann, Eradication of Helicobacter pylori does not significantly improve dyspepsia - Comment, PRESSE MED, 28(12), 1999, pp. 634-634
Eradication of Helicobacter pylori does not significantly improve dyspepsia
Authors: McColl, K Bergmann, JF
Citation: K. Mccoll et Jf. Bergmann, Eradication of Helicobacter pylori does not significantly improve dyspepsia, PRESSE MED, 28(12), 1999, pp. 634-634
Familial adenomatous polyposis: role of sulindac
Authors: Landauer, S Halimi, C Caulin, C Bergmann, JF
Citation: S. Landauer et al., Familial adenomatous polyposis: role of sulindac, THERAPIE, 54(6), 1999, pp. 675-682
Intestinal absorption and permeability in human immunodeficiency virus-infected patients
Authors: Pernet, P Vittecoq, D Kodjo, A Randrianarisolo, MH Dumitrescu, L Blondon, H Bergmann, JF Giboudeau, J Aussel, C
Citation: P. Pernet et al., Intestinal absorption and permeability in human immunodeficiency virus-infected patients, SC J GASTR, 34(1), 1999, pp. 29-34
Risultati: 1-25 | 26-29